ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
U.S. Gold Corp. benefits from record gold prices, a strong project pipeline, and inclusion in Russell indices. Read why USAU ...
On January 3, 2026, Kalshi's NBA prediction markets saw volatility, with Keyonte George's price dropping 58.33%, Victor Wembanyama's down 25%, and playoff odds for Dallas and Portland declining.
The Daily Overview on MSNOpinion
Why a 2026 market pullback may be closer than investors think
U.S. stocks are entering 2026 after a powerful multi‑year rally, with valuations stretched and optimism running high. History ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback